Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial

被引:44
|
作者
Reimer, Jens [1 ]
Verthein, Uwe [1 ]
Karow, Anne [1 ]
Schaefer, Ingo [1 ]
Naber, Dieter [1 ]
Haasen, Christian [1 ]
机构
[1] Univ Hamburg, Ctr Interdisciplinary Addict Res, Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany
关键词
Comorbidity; heroin; injection drug use; maintenance treatment; methadone; outcome; HEROIN-ASSISTED TREATMENT; HIV-INFECTION; HEPATITIS-C; DRUG-USE; METHADONE; ADDICTS; COMORBIDITY; PREVALENCE; SCALE;
D O I
10.1111/j.1360-0443.2011.03463.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To evaluate physical and mental health and compare treatment outcomes in opiate-dependent patients substituted either with heroin or methadone. Design Twelve-month open-label randomized controlled trial. Setting Out-patient substitution clinics in seven German cities. Participants A total of 1015 opiate-dependent individuals. Measurements Opiate Treatment Index-Health Scale Score (OTI), Body Mass Index (BMI), serology for infectious diseases such as hepatitis B, C and human immunodeficiency virus as well as tuberculosis, Karnofsky Performance Scale (KPS), electrocardiogram (ECG), echocardiogram, Symptom Checklist 90-R (SCL-90-R), Global Assessment of Functioning (GAF), Modular System for Quality of Life and study medication-related serious adverse events (SAE). Findings Improvements were found in both heroin and methadone substituted patients regarding OTI, BMI, KPS, SCL-90-R, and GAF, but they were more pronounced for the heroin group (analysis of variance, all P = 0.000). The frequency of pathological echocardiograms decreased in the heroin group and increased in the methadone group (chi(2) test, < 0.05). Markers for infectious diseases and frequencies of pathological ECGs did not differ between baseline and 12 months, or between treatment groups. Studymedication-related serious adverse events, all of which were treated successfully, occurred 2.5 times more often in the heroin group. The majority of heroin-related SAEs (41 of 58) occurred within a few minutes of the injections. Conclusions The integration of severe injection drug users either in methadone or heroin-assisted maintenance treatment has positive effects on most physical and mental change-sensitive variables, with heroin showing superior results. Due to medication-related adverse events, patients should be observed for 15 minutes after a heroin injection.
引用
收藏
页码:1647 / 1655
页数:9
相关论文
共 50 条
  • [21] Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics
    Groshkova, Teodora
    Metrebian, Nicola
    Hallam, Christopher
    Charles, Vikki
    Martin, Anthea
    Forzisi, Luciana
    Lintzeris, Nicholas
    Strang, John
    DRUG AND ALCOHOL REVIEW, 2013, 32 (06) : 566 - 573
  • [22] Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment
    Rabl, Josef
    Specka, Michael
    Bonnet, Udo
    Irturk, Ozge
    Schifano, Fabrizio
    Scherbaum, Norbert
    PHARMACOPSYCHIATRY, 2025, 58 (02) : 88 - 94
  • [23] Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
    Roux, Perrine
    Castro, Daniela Rojas
    Ndiaye, Khadim
    Madrid, Laelia Briand
    Laporte, Virginie
    Mora, Marion
    Maradan, Gwenaelle
    Morel, Stephane
    Spire, Bruno
    Carrieri, Patrizia
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2017, 12
  • [24] Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: A longitudinal study
    Tsui, Judith I.
    Anderson, Bradley J.
    Strong, David R.
    Stein, Michael D.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2014, 40 (02) : 163 - 169
  • [25] Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials
    Moazen-Zadeh, Ehsan
    Ziafat, Kimia
    Yazdani, Kiana
    Kamel, Mostafa M.
    Wong, James S. H.
    Modabbernia, Amirhossein
    Blanken, Peter
    Verthein, Uwe
    Schutz, Christian G.
    Jang, Kerry
    Akhondzadeh, Shahin
    Krausz, R. Michael
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2021, 47 (03) : 280 - 304
  • [26] Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
    Nasim Zamani
    Nicholas A. Buckley
    Hossein Hassanian-Moghaddam
    Critical Care, 24
  • [27] Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial
    Solli, Kristin Klemmetsby
    Kunoe, Nikolaj
    Latif, Zill-E-Huma
    Sharma-Haase, Kamni
    Opheim, Arild
    Krajci, Peter
    Gaulen, Zhanna
    Benth, Jurate Saltyte
    Tanum, Lars
    EUROPEAN ADDICTION RESEARCH, 2019, 25 (06) : 303 - 309
  • [28] Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
    Zamani, Nasim
    Buckley, Nicholas A.
    Hassanian-Moghaddam, Hossein
    CRITICAL CARE, 2020, 24 (01):
  • [29] Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy
    Schaefer, Arne
    Wittchen, Hans-Ulrich
    Backmund, Markus
    Soyka, Michael
    Golz, Jorg
    Siegert, Jens
    Schaefer, Martin
    Tretter, Felix
    Kraus, Michael R.
    ADDICTION, 2009, 104 (04) : 630 - 640
  • [30] Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients
    Ledgerwood, David M.
    Lister, Jamey J.
    LaLiberte, Benjamin
    Lundahl, Leslie H.
    Greenwald, Mark K.
    ADDICTIVE BEHAVIORS, 2019, 90 : 191 - 195